All Online

13 - 24 of 70 results

Refine

Active filters

Infectious Diseases

Influenza Management

0.75 CME/MOC
1.08 AANP | 0.88 Pharmacology


1 CME CREDIT

In the eighth episode of Pri-Med’s weekly web series on COVID-19, faculty will continue their discussion on treatment by describing immunomodulatory therapies and additional antivirals under investigation for COVID-19. They will also review the various types of vaccines currently in development for COVID-19. Specific therapies to be discussed in this episode will include: • Antivirals: baloxavir marboxil, favipiravir, nitazoxanide, oseltamivir, ribavirin, umifenovir • Glucocorticoids • Anakinra • Tocilizumab • Interferon beta-1b • Vaccine mRNA-1273 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/21/2020 and they are subject to change as new information is published.


In the fourth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the clinical presentation and diagnosis of COVID-19. In addition to describing the various methods of COVID-19 testing, they will review data regarding the presentation of patients with COVID-19, including history, physical exam, labs, and imaging findings. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/23/2020 and they are subject to change as new information is published.


In the fifth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss strategies for adapting clinical practice to virtual platforms and explain how telehealth has changed as a result of the COVID-19 pandemic. They will review requirements for providing various types of telehealth visits (audio only vs. audio plus video) and share practical advice on getting reimbursed for these encounters, including review of common billing codes. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 4/28/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the adoption of and barriers to telemedicine in the COVID-19 pandemic and examine the emerging data on ivermectin and fluvoxamine for the treatment of patients with COVID-19.


1.5 CME CREDITS

This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.


1 CME CREDIT

COVID-19 Panel Discussion

1.00 CME/MOC
1.00 AANP


1 CME CREDIT

COVID-19 Panel Discussion: February 2021

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


0.5 CME CREDIT

In the seventeenth episode of Pri-Med’s weekly web series on COVID-19, faculty will explore how the COVID-19 pandemic has influenced non-communicable diseases and impacted healthcare beyond SARS-CoV-2 infection. Faulty will also discuss the role of masks to reduce the risk of respiratory infections and compare the efficiency of different masks. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 09/01/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Join us for the final COVID-19 Pulse session of 2020! In the twenty-third episode of Pri-Med’s web series on COVID-19, faculty revisit the discussion of monoclonal antibodies, with a more in-depth look at the recent data and recommendations on monoclonal antibody use in COVID-19. Our learners also continue to have many questions about the relationship between COVID-19 and thrombotic complications. This session will discuss those questions as well as prophylaxis and treatment for venous thromboembolism in patients with COVID-19. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions, including those about recent vaccine updates. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.


1 CME CREDIT

This session will approach three challenging areas of infectious disease that the primary care clinician faces on a regular basis: sexually transmitted infections, vaccination, and hepatitis. In the past few years, there has been a tremendous rise in the incidence of sexually transmitted infections. Faculty will update the audience on recent developments in the management of patients with sexually transmitted infections. Also continually updated, are the guidelines on adult vaccination. This session will provide updates on the adult vaccination schedule. Lastly, faculty will discuss the epidemiology of viral hepatitis.


1 CME CREDIT

Clinicians often find themselves navigating a gauntlet of choices when recommending over the counter (OTC) medications for an acute viral respiratory illness. Decisions about NSAIDs, acetaminophen and aspirin to manage pain, inflammation and fever may now be more complicated given the COVID-19 pandemic. This session will dispel common misunderstandings about pain and fever reducing medications, with a focused discussion on some of the recent misconceptions surrounding NSAID use in relation to COVID-19. Faculty will present appropriate applications of NSAIDs and acetaminophen, based on current literature and evidence-based data.